Evidence map›Paper›PMID 31016358›Full record

ArticleDiabetologia2019

Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter].

Jessica L Dunne, Sarah J Richardson, Mark A Atkinson, Maria E Craig, Knut Dahl-Jørgensen, Malin Flodström-Tullberg, Heikki Hyöty, Richard E Lloyd, Noel G Morgan, Alberto Pugliese

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Diabetologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jessica L DunneJDRF, 26 Broadway, 14th Floor, New York, NY, 10004, USA. JDunne@JDRF.org.ORCID http://orcid.org/0000-0002-0134-4177
Sarah J RichardsonInstitute of Biomedical and Clinical Science, University of Exeter Medical School, RILD Building, Barrack Road, Exeter, EX2 5DW, UK. S.Richardson@exeter.ac.uk.
Mark A AtkinsonDepartments of Pathology and Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA.
Maria E CraigSchool of Women's and Children's Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia.
Knut Dahl-JørgensenDepartment of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Malin Flodström-TullbergCenter for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Heikki HyötyFaculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Richard E LloydDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Noel G MorganInstitute of Biomedical and Clinical Science, University of Exeter Medical School, RILD Building, Barrack Road, Exeter, EX2 5DW, UK.
Alberto PuglieseDiabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, USA.

Funding

Medical Research Council MR/P010695/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsDiabetes Mellitus, Type 1EnterovirusEnterovirus InfectionsHumansVaccinationAntiviral AgentsAntiviral agentsClinical trialsDiViDEnterovirusIsletnPOD

Identifiers

PMID31016358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.